ArticleBMC cancer2020

BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.

Evelina Miele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.